← Back to Search

Behavioral Intervention

TranS-C for Sleep Wake Disorder

N/A
Waitlist Available
Led By Christopher C Imes, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months
Awards & highlights

Study Summary

This trial will study if the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) is a feasible and acceptable treatment for adults with poor sleep and excess weight. The study will also explore if TranS-C improves sleep health and cardiovascular outcomes.

Eligible Conditions
  • Sleep Wake Disorder
  • Sleep Disorders
  • Sleep Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attrition rate
Completeness of questionnaire responses
Recruitment rate
Secondary outcome measures
Change in alertness
Change in body mass index
Change in composite sleep health score
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
TranS-C
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TranS-C
2021
N/A
~200

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,722 Previous Clinical Trials
16,342,917 Total Patients Enrolled
Christopher C Imes, PhDPrincipal InvestigatorUniversity of Pittsburgh

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025